Understand the source comparison
How FDA Regulation Defines Legal Peptide Use vs Illegal Marketing
The FDA distinguishes between the substance itself and the claims made about it. GHRP-6 acetate is not illegal. Marketing it for human consumption without FDA approval is illegal. This distinction is codified in Section 201(g)(1) of the Federal Food, Drug, and
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- The FDA distinguishes between the substance itself and the claims made about it. GHRP-6 acetate is not illegal. Marketing it for human consumption without FDA approval is illegal. This distinction is codified in Section 201(g)(1) of the Federal Food, Drug, and Cosmetic Act, which defines a drug as any article 'intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease' or 'intended to affect the structure or any function of the body.' Intent is determined by labeling, marketing materials, and the context of sale. Not by the molecule's inherent properties. A supplier who sells GHRP-6 acetate with the label 'for research use only' and provides no dosing instructions, no therapeutic claims, and no suggestion of human administration is selling a research chemical. A supplier who sells the same molecule with language like 'supports lean muscle development' or 'enhances recovery' is selling an unapproved new drug.
- Enforcement follows this framework consistently. FDA Warning Letters issued to peptide suppliers between 2021 and 2026 cite specific marketing language as the violation. Not the sale of peptides themselves. A representative Warning Letter issued to a supplier in 2024 stated: 'Your products are drugs under section 201(g)(1) of the Act because they are intended for use in the cure, mitigation, treatment, or prevention of disease and/or intended to affect the structure or any function of the body. Your products are also new drugs under section 201(p) of the Act because they are not generally recognized as safe and effective for their labeled uses.' The cited evidence was website copy describing peptide benefits for 'anti-aging,' 'muscle growth,' and 'recovery.' The peptides themselves were not prohibited. The therapeutic claims were.
- This is the enforcement pattern labs must understand: the FDA regulates commercial speech and marketing claims, not basic research. Universities conducting GHRP-6 acetate studies under Institutional Review Board protocols face no legal barriers. Research labs studying ghrelin receptor mechanisms in cell cultures or animal models operate within clear legal boundaries. The line is crossed when a commercial entity markets GHRP-6 acetate to consumers with the implied or explicit suggestion that it will produce therapeutic outcomes in humans. That's when 'research peptide' becomes 'unapgroved drug' in the eyes of the FDA.
- Is GHRP-6 acetate legal if purchased from offshore suppliers? Technically yes for research use, but enforcement risk increases. Peptides manufactured outside the United States and imported without proper documentation can be detained by Customs and Border Protection under 21 CFR 1.83, which allows refusal of entry for unapproved drugs. Domestic suppliers like Real Peptides manufacture under USP standards within FDA-registered facilities, which eliminates import compliance risk entirely. Our full peptide collection is synthesized domestically using small-batch exact amino-acid sequencing. Ensuring both purity and legal compliance at the source.